JIAN YING HUANG
Esthetician in Philadelphia, PA

License number
Pennsylvania 000134
Category
Cosmetology
Type
Esthetician Temp Authority to Practice
Address
Address
Philadelphia, PA 19149

Personal information

See more information about JIAN YING HUANG at radaris.com
Name
Address
Phone
Jian Huang
4163 N Darien St, Philadelphia, PA 19140
(215) 227-2267
Jian Huang
5160 Montour St, Philadelphia, PA 19124
(215) 535-3212
Jian Huang, age 50
4629 Pennypack St, Philadelphia, PA 19136
(215) 708-1798
Jian Huang
330 E 8Th Ave, Tarentum, PA 15084
(215) 865-4928
Jian Huang
801 Hammersmith Ct, Avondale, PA 19311
(610) 268-2160

Professional information

Jian Huang Photo 1

Risk Strategy Analyst At Bank Of America

Position:
VP, Risk Stat Analyst III at Bank of America
Location:
Greater Philadelphia Area
Industry:
Banking
Work:
Bank of America since Aug 2006 - VP, Risk Stat Analyst III
Education:
Rutgers, The State University of New Jersey-New Brunswick 2002 - 2004
MS, Statistics


Jian Huang Photo 2

Jian Huang - Philadelphia, PA

Work:
VOYA Financial
Financial Analysis
Drexel University - Philadelphia, PA
School Project
The Campaign - Philadelphia, PA
Volunteer Income Tax Assistance
Bellevue College Bookstore - Bellevue, WA
Customer Service
Hope-Link - Bellevue, WA
Office Assistant
Education:
Drexel University - P
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting
Drexel University - p
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting
Drexel University - Philadelphia, PA
Bachelor of Science in Business Administration
Skills:
Computer: Proficient in Excel, Word and PowerPoint


Jian Huang Photo 3

In Vivo And Ex Vivo Expansion Of Hematopoietic Stem Cells With A Targeted Combination Of Clinically Tested, Fda Approved Drugs

US Patent:
2011025, Oct 13, 2011
Filed:
Apr 11, 2011
Appl. No.:
13/084180
Inventors:
Peter S. Klein - Wynnewood PA, US
Jian Huang - Philadelphia PA, US
International Classification:
A61M 37/00, A61K 35/28, A61P 35/00, A61P 7/06, A61P 19/08, C12N 5/0775, A61P 35/02
US Classification:
604522, 435375, 435372, 435325, 424 937
Abstract:
The present invention provides a therapeutic approach to maintain and expand HSCs in vivo using currently available medications that target GSK-3 and mTOR. The present invention also provides a system and method for the ex vivo culturing of HSCs, where an mTOR inhibitor is combined with a GSK-3 inhibitor within the culturing conditions.